ADC Therapeutics America Inc

About ADC Therapeutics America Inc

ADC Therapeutics America Inc is a commercial, global leader and pioneer in the field of antibody-drug conjugates (ADCs), specializing in transforming cancer treatment. The company has developed ZYNLONTA® (loncastuxamab tesirine lpyl), an ADC that has received accelerated approval in the United States for relapsed/refractory non-Hodgkin lymphoma and is being evaluated in various therapeutic combinations.

Career Opportunities

ADC Therapeutics America Inc offers a mission-driven work environment where employees are dedicated to making a difference in patients‘ lives. The company fosters professional growth and stability, encouraging talented individuals to join their innovative team.

• Mission-driven culture focused on patient impact
• Opportunities for professional development and career advancement
• Collaborative and supportive working environment